ArticleBritish journal of haematology2026

Elevated desmoglein-2 expression in multiple myeloma is a prognostic marker across genomic subtypes with impact on high-risk cytogenetics and a distinct gene expression profile.

Barbara J McClure et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.